Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jul 2025 for ArriVent Biopharma, Inc., €3,994. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Robin LaChapelle: trading record in brief
All filings by Robin LaChapelle on record concern ArriVent Biopharma, Inc. Over a trading history stretching from 19 September 2024 to 11 July 2025, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 15 July 2025, the filings show an option exercise worth €3,994 in ArriVent Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robin LaChapelle
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,050 shares@ US$2.2810.8% of flowCommon StockSEC:0001104659-25-067928:0
2,600 shares@ US$2.2813.8% of flowCommon StockSEC:0001104659-25-067928:1
6,503 shares@ US$2.2834.4% of flowCommon StockSEC:0001104659-25-067928:2
2,700 shares@ US$6.2441.0% of flowCommon StockSEC:0001104659-24-102146:0
4 of 4 declarations
